Karel Souček (Karel Soucek)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 24

Top Topics

Radical Prostatectomy

Top Venues

Scientific reports

Cell death & disease

Molecular oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Andrej Besse, Lenka Sedlarikova, Lorina Buechler, Marianne Kraus, Chieh-Hsiang Yang, Nicol Strakova, Karel Souček, Jiri Navratil, Marek Svoboda, Alana L Welm, Markus Joerger, Christoph Driessen, Lenka Besse
HIV-protease inhibitors potentiate the activity of carfilzomib in triple-negative breast cancer. British journal of cancer 131 (5) (2024)
Markéta Pícková, Zuzana Kahounová, Tomasz Radaszkiewicz, Jiřina Procházková, Radek Fedr, Michaela Nosková, Katarzyna Anna Radaszkiewicz, Petra Ovesná, Vítězslav Bryja, Karel Souček
Orthotopic model for the analysis of melanoma circulating tumor cells. Scientific reports 14 (1) (2024)
Markéta Pícková, Zuzana Kahounová, Tomasz Radaszkiewicz, Jiřina Procházková, Radek Fedr, Michaela Nosková, Katarzyna Anna Radaszkiewicz, Petra Ovesná, Vítězslav Bryja, Karel Souček
Orthotopic model for the analysis of melanoma circulating tumor cells. Scientific reports 14 (1) (2024)
Jiřina Procházková, Zuzana Kahounová, Jan Vondráček, Karel Souček
Aryl hydrocarbon receptor as a drug target in advanced prostate cancer therapy - obstacles and perspectives. Transcription (2024)
Andrej Besse, Lenka Sedlarikova, Lorina Buechler, Marianne Kraus, Chieh-Hsiang Yang, Nicol Strakova, Karel Souček, Jiri Navratil, Marek Svoboda, Alana L Welm, Markus Joerger, Christoph Driessen, Lenka Besse
HIV-protease inhibitors potentiate the activity of carfilzomib in triple-negative breast cancer. British journal of cancer (2024)
Zuzana Kahounová, Markéta Pícková, Stanislav Drápela, Jan Bouchal, Eva Szczyrbová, Jiří Navrátil, Karel Souček
Correction: Circulating tumor cell-derived preclinical models: current status and future perspectives. Cell death & disease 15 (7) (2024)
Zuzana Kahounová, Markéta Pícková, Stanislav Drápela, Jan Bouchal, Eva Szczyrbová, Jiří Navrátil, Karel Souček
Correction: Circulating tumor cell-derived preclinical models: current status and future perspectives. Cell death & disease 15 (7) (2024)
Markéta Pícková, Zuzana Kahounová, Tomasz Radaszkiewicz, Jiřina Procházková, Radek Fedr, Michaela Nosková, Katarzyna Anna Radaszkiewicz, Petra Ovesná, Vítězslav Bryja, Karel Souček
Orthotopic model for the analysis of melanoma circulating tumor cells. Scientific reports 14 (1) (2024)
Stanislav Drápela, Barbora Kvokačková, Eva Slabáková, Anna Kotrbová, Kristína Gömöryová, Radek Fedr, Daniela Kurfürstová, Martin Eliáš, Vladimír Študent, Frederika Lenčéšová, Ganji Sri Ranjani, Vendula Pospíchalová, Vítězslav Bryja, Wytske M van Weerden, Martin Puhr, Zoran Culig, Jan Bouchal, Karel Souček
Pre-existing cell subpopulations in primary prostate cancer tumors display surface fingerprints of docetaxel-resistant cells. Cellular oncology (Dordrecht, Netherlands) (2024)
Markéta Pícková, Zuzana Kahounová, Tomasz Radaszkiewicz, Jiřina Procházková, Radek Fedr, Michaela Nosková, Katarzyna Anna Radaszkiewicz, Petra Ovesná, Vítězslav Bryja, Karel Souček
Orthotopic model for the analysis of melanoma circulating tumor cells. Scientific reports 14 (1) (2024)
Zuzana Kahounová, Markéta Pícková, Stanislav Drápela, Jan Bouchal, Eva Szczyrbová, Jiří Navrátil, Karel Souček
Circulating tumor cell-derived preclinical models: current status and future perspectives. Cell death & disease 14 (8) (2023)
Hana Kotasová, Michaela Capandová, Vendula Pelková, Jana Dumková, Zuzana Sumbalova Koledova, Ján Remšík, Karel Souček, Zuzana Garlíková, Veronika Sedlakova, Anas Rabata, Petr Vanhara, Lukáš Moráň, Lukáš Pečinka, Volodymyr Porokh, Martin Kučírek, Libor Streit, Josef Havel, Aleš Hampl
Expandable Lung Epithelium Differentiated from Human Embryonic Stem Cells. Tissue engineering and regenerative medicine 19 (5) (2022)
Kamila Říhová, Monika Dúcka, Iva Staniczková Zambo, Ladislava Vymětalová, Martin Šrámek, Filip Trčka, Jan Verner, Stanislav Drápela, Radek Fedr, Tereza Suchánková, Barbora Pavlatovská, Eva Ondroušková, Irena Kubelková, Danica Zapletalová, Štěpán Tuček, Peter Múdry, Dagmar Adámková Krákorová, Lucia Knopfová, Jan Šmarda, Karel Souček, Lubor Borsig, Petr Beneš
Transcription factor c-Myb: novel prognostic factor in osteosarcoma. Clinical & experimental metastasis 39 (2) (2022)
Barbora Kvokačková, Radek Fedr, Daniela Kužílková, Jan Stuchlý, Adéla Vávrová, Jiří Navrátil, Pavel Fabian, Róbert Ondruššek, Petra Ovesná, Ján Remšík, Jan Bouchal, Tomáš Kalina, Karel Souček
Single-cell protein profiling defines cell populations associated with triple-negative breast cancer aggressiveness. Molecular oncology (2022)
Barbora Kvokačková, Radek Fedr, Daniela Kuzilkova, Jan Stuchlý, Adéla Vávrová, Jiří Navrátil, Pavel Fabian, Róbert Ondruššek, Petra Ovesná, Ján Remšík, Jan Bouchal, Tomáš Kalina, Karel Souček
Single-cell protein profiling defines cell populations associated with triple-negative breast cancer aggressiveness. Molecular oncology (2022)
Barbora Kvokačková, Ján Remšík, Mohit Kumar Jolly, Karel Souček
Phenotypic Heterogeneity of Triple-Negative Breast Cancer Mediated by Epithelial-Mesenchymal Plasticity. Cancers 13 (9) (2021)
Alena Mickova, Gvantsa Kharaishvili, Daniela Kurfurstova, Mariam Gachechiladze, Milan Král, Ondrej Vacek, Barbora Pokryvkova, Martin Mistrik, Karel Souček, Jan Bouchal
Skp2 and Slug Are Coexpressed in Aggressive Prostate Cancer and Inhibited by Neddylation Blockade. International journal of molecular sciences 22 (6) (2021)
Eva Slabáková, Zuzana Kahounová, Jiřina Procházková, Karel Souček
Regulation of Neuroendocrine-like Differentiation in Prostate Cancer by Non-Coding RNAs. Non-coding RNA 7 (4) (2021)
Ján Remšík, Markéta Pícková, Ondřej Vacek, Radek Fedr, Lucia Binó, Aleš Hampl, Karel Souček
TGF-β regulates Sca-1 expression and plasticity of pre-neoplastic mammary epithelial stem cells. Scientific reports 10 (1) (2020)
Sára Lenárt, Peter Lenárt, Jan Šmarda, Ján Remšík, Karel Souček, Petr Beneš
Trop2: Jack of All Trades, Master of None. Cancers 12 (11) (2020)
Ximena Maria Muresan, Jan Bouchal, Zoran Culig, Karel Souček
Toll-Like Receptor 3 in Solid Cancer and Therapy Resistance. Cancers 12 (11) (2020)
Stanislav Drápela, Prashant Khirsariya, Thomas A Kirkland, Radek Fedr, Tereza Suchánková, Diana Búzová, Jan Cerveny, Aleš Hampl, Martin Puhr, William R Watson, Zoran Culig, Lumír Krejčí, Kamil Paruch, Karel Souček
The CHK1 inhibitor MU380 significantly increases the sensitivity of human docetaxel-resistant prostate cancer cells to gemcitabine through the induction of mitotic catastrophe. Molecular oncology 14 (10) (2020)
Šárka Šimečková, Zuzana Kahounová, Radek Fedr, Ján Remšík, Eva Slabáková, Tereza Suchánková, Jiřina Procházková, Jan Bouchal, Gvantsa Kharaishvili, Milan Král, Petr Beneš, Karel Souček
High Skp2 expression is associated with a mesenchymal phenotype and increased tumorigenic potential of prostate cancer cells. Scientific reports 9 (1) (2019)
Karel Souček, Alice Malenovská, Zuzana Kahounová, Ján Remšík, Zuzana Holubcová, Tomáš Soukup, Daniela Kurfürstová, Jan Bouchal, Tereza Suchánková, Eva Slabáková, Aleš Hampl
Presence of growth/differentiation factor-15 cytokine in human follicular fluid, granulosa cells, and oocytes. Journal of assisted reproduction and genetics 35 (8) (2018)